Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Oxford University Press
2016
|
| _version_ | 1826287973763645440 |
|---|---|
| author | Meyer, T Qian, W Valle, J Talbot, D Cunningham, D Reed, N Wall, L Waters, J Ross, P Anthoney, A Sumpter, K Sarwar, N Crosby, T Begum, N Young, G Hardy, R Corrie, P |
| author_facet | Meyer, T Qian, W Valle, J Talbot, D Cunningham, D Reed, N Wall, L Waters, J Ross, P Anthoney, A Sumpter, K Sarwar, N Crosby, T Begum, N Young, G Hardy, R Corrie, P |
| author_sort | Meyer, T |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T02:06:43Z |
| format | Conference item |
| id | oxford-uuid:9f403dd6-d774-42f4-95d7-a55fd6839115 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T02:06:43Z |
| publishDate | 2016 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:9f403dd6-d774-42f4-95d7-a55fd68391152022-03-27T00:56:03ZCapecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trialConference itemhttp://purl.org/coar/resource_type/c_5794uuid:9f403dd6-d774-42f4-95d7-a55fd6839115Symplectic Elements at OxfordOxford University Press2016Meyer, TQian, WValle, JTalbot, DCunningham, DReed, NWall, LWaters, JRoss, PAnthoney, ASumpter, KSarwar, NCrosby, TBegum, NYoung, GHardy, RCorrie, P |
| spellingShingle | Meyer, T Qian, W Valle, J Talbot, D Cunningham, D Reed, N Wall, L Waters, J Ross, P Anthoney, A Sumpter, K Sarwar, N Crosby, T Begum, N Young, G Hardy, R Corrie, P Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial |
| title | Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial |
| title_full | Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial |
| title_fullStr | Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial |
| title_full_unstemmed | Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial |
| title_short | Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial |
| title_sort | capecitabine and streptozocin cisplatin for gastroenteropancreatic neuroendocrine tumours predictors of long term survival in the net01 trial |
| work_keys_str_mv | AT meyert capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT qianw capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT vallej capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT talbotd capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT cunninghamd capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT reedn capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT walll capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT watersj capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT rossp capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT anthoneya capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT sumpterk capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT sarwarn capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT crosbyt capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT begumn capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT youngg capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT hardyr capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial AT corriep capecitabineandstreptozocincisplatinforgastroenteropancreaticneuroendocrinetumourspredictorsoflongtermsurvivalinthenet01trial |